PReS-FINAL-2158: Effect of canakinumab on functional ability and health-related quality of life in systemic juvenile idiopathic arthritis (SJIA) patients.
about
PReS-FINAL-2158: Effect of canakinumab on functional ability and health-related quality of life in systemic juvenile idiopathic arthritis (SJIA) patients.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
PReS-FINAL-2158: Effect of can ...... hic arthritis (SJIA) patients.
@en
PReS-FINAL-2158: Effect of can ...... juvenile idiopathic arthritis
@nl
type
label
PReS-FINAL-2158: Effect of can ...... hic arthritis (SJIA) patients.
@en
PReS-FINAL-2158: Effect of can ...... juvenile idiopathic arthritis
@nl
prefLabel
PReS-FINAL-2158: Effect of can ...... hic arthritis (SJIA) patients.
@en
PReS-FINAL-2158: Effect of can ...... juvenile idiopathic arthritis
@nl
P2093
P1476
PReS-FINAL-2158: Effect of can ...... hic arthritis (SJIA) patients.
@en
P2093
K Lheritier
P2888
P304
P356
10.1186/1546-0096-11-S2-P170
P433
P577
2013-12-05T00:00:00Z
P6179
1026170816